≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Testicular hypofunction

DOID EFO Endpoint Browser PheWeb

E4_TESTICHYPO

testicular disease: A non-neoplastic or neoplastic disorder affecting the testis. Representative examples include torsion, infarction, germ cell tumor, sex cord-stromal tumor, lymphoma, and leukemia.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E29.1#
  • Hospital discharge: ICD-9 — 257[1-2]
  • Hospital discharge: ICD-8 — 2571
  • Cause of death: ICD-10 — E29.1#
  • Cause of death: ICD-9 — 257[1-2]
  • Cause of death: ICD-8 — 2571
  • KELA reimbursements: KELA codes — ANY
  • KELA reimbursements: ICD-10 — E29.1#

3 out of 7 registries used, show all original rules.

1175

4. Check minimum number of events

None

1175

5. Include endpoints

None

1175

6. Filter based on genotype QC (FinnGen only)

1175

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E29
Name in latin
Hypofunctio testium

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4793 - 4793
Only index persons 4698 - 4698
Unadjusted period prevalence (%)
Whole population 0.13 - 0.13
Only index persons 0.18 - 0.18
Median age at first event (years)
Whole population - - 48.75
Only index persons - - 48.71

-FinnGen-

Key figures

All Female Male
Number of individuals 1175 - 1175
Unadjusted period prevalence (%) 0.52 - 0.52
Median age at first event (years) 51.77 - 51.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1039
Matched controls
10390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
175.9
323.0
911
402
121
Kela drug reimbursment
Severe hypofunction of sexual glands
875.8
323.0
389
7
E29.1
ICD-10 Finland
Testicular hypofunction
1303.7
323.0
871
41
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
75.9
142.9
161
25
Y28
ICPC
Limited function/disability (Y)
74.5
84.0
95
14
A50
ICPC
General and Unspecified, Medication/prescr/renewal
13.7
75.1
134
111
A55
ICPC
General and Unspecified, Local injection/infiltration
18.5
53.8
84
49
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
50.4
48
*
G47.3
ICD-10 Finland
Sleep apnoea
2.8
48.1
409
1934
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.6
39.1
82
92
G03GA01
ATC
chorionic gonadotrophin; parenteral
39.5
39.1
49
13
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
37.8
37.1
47
13
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.3
34.9
446
2523
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.3
32.0
88
150
T99
ICPC
Endocr/metab/nutrit disease other
19.3
31.6
48
26
R5140
NOMESCO Finland
Monitoring the use of the aid
3.0
30.7
197
744
KFC00
NOMESCO Finland
Unilateral orchiectomy
13.6
29.9
52
40
G04CA01
ATC
alfuzosin; oral
2.8
29.0
220
919
N48.4
ICD-10 Finland
Impotence of organic origin
5.5
27.5
84
163
N06AX11
ATC
mirtazapine; oral
2.2
27.1
349
1923
M01AH05
ATC
etoricoxib; oral
2.0
25.9
651
4707
H03AA01
ATC
levothyroxine sodium; systemic
3.1
25.8
158
572
N02AX02
ATC
tramadol; systemic, rectal
2.0
25.5
463
2935
N06AB10
ATC
escitalopram; oral
2.5
24.8
234
1096
N03AX16
ATC
pregabalin; oral
2.4
24.5
256
1267
A02BC05
ATC
esomeprazole; systemic
2.0
23.5
402
2464
N05BA04
ATC
oxazepam; oral
2.3
22.5
240
1192
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
22.4
433
2770
N06AX12
ATC
bupropion; oral
3.5
21.9
109
339
A02BC02
ATC
pantoprazole; systemic
1.9
21.8
607
4419
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
21.7
505
3444
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
21.7
431
2775
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
51.1
21.2
25
5
N05AH04
ATC
quetiapine; oral
2.3
20.9
213
1033
J01DB01
ATC
cefalexin; oral
2.1
20.8
844
7002
N62
ICD-10 Finland
Hypertrophy of breast
10.1
20.7
41
42
R03AC02
ATC
salbutamol; inhalant
1.9
20.1
484
3311
N03AX12
ATC
gabapentin; oral
2.5
20.0
174
775
T55
ICPC
Metabolic, Local injection/infiltration
58.7
20.0
23
*
N05CF02
ATC
zolpidem; oral
2.4
19.9
197
936
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
19.8
170
749
Q98.0
ICD-10 Finland
Klinefelter syndrome karyotype 47,XXY
75.0
19.8
22
*
R53
ICD-10 Finland
Malaise and fatigue
2.5
19.6
177
803
J01MA02
ATC
ciprofloxacin; systemic
1.9
19.4
384
2442
N06AX21
ATC
duloxetine; oral
2.9
19.3
127
479
J01CA04
ATC
amoxicillin; systemic
2.0
19.3
806
6625
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
11.3
19.3
36
33
J01FA10
ATC
azithromycin; systemic
1.8
19.2
566
4122
N06AX16
ATC
venlafaxine; oral
2.5
19.1
169
759
M03BX02
ATC
tizanidine; oral
1.8
18.9
656
5031
N05CF01
ATC
zopiclone; oral
2.0
18.8
296
1725
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
18.7
186
886
N06AX26
ATC
vortioxetine; oral
3.5
18.5
89
269
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
18.2
287
1671
N46
ICD-10 Finland
Male infertility
4.9
17.9
59
126
-50
ICPC
Medication/prescr/renewal
4.6
17.7
62
141
D75.1
ICD-10 Finland
Secondary polycythaemia
12.7
17.7
31
25
N06AB04
ATC
citalopram; systemic
2.1
16.9
207
1082
R01AD09
ATC
mometasone; nasal
1.8
16.8
428
2930
M01AE02
ATC
naproxen; oral, rectal
1.7
16.5
543
4016
M03BC51
ATC
orphenadrine, combinations; systemic
1.9
16.5
285
1705
M54.5
ICD-10 Finland
Low back pain
1.9
16.4
324
2033
N02BE01
ATC
paracetamol; systemic, rectal
1.9
16.2
817
6882
M01AB05
ATC
diclofenac; systemic, rectal
1.7
16.0
695
5566
A02BC03
ATC
lansoprazole; oral
1.9
15.9
260
1518
XKD00
NOMESCO Finland
Uroflowmetry
2.1
15.9
196
1025
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
15.7
15
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
15.7
15
*
WX723
NOMESCO Finland
CPAP therapy
3.4
15.5
77
240
J01AA02
ATC
doxycycline; systemic
1.8
15.4
745
6123
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
16.3
15.3
24
15
R06AX27
ATC
desloratadine; oral
1.9
15.3
250
1459
H02AB06
ATC
prednisolone; systemic
1.7
15.2
412
2852
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
15.1
498
3648
T28
ICPC
Limited function/disability (T)
10.3
15.0
29
29
R01AD12
ATC
fluticasone furoate; nasal
1.9
14.9
282
1736
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.5
14.8
70
210
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.2
14.7
56
139
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
14.7
137
629
R06.0
ICD-10 Finland
Dyspnoea
2.0
14.7
208
1147
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
14.6
322
2079
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
14.5
100
388
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
14.5
274
1679
Q98.4
ICD-10 Finland
Klinefelter syndrome, unspecified
152.0
14.5
15
*
L02BA01
ATC
tamoxifen; oral
27.6
14.3
19
7
H02AB09
ATC
hydrocortisone; systemic
7.5
14.3
33
45
R01AD08
ATC
fluticasone; nasal
1.8
14.3
280
1740
ZXE00
NOMESCO Finland
One hour or less
1.8
14.2
346
2303
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
14.2
101
398
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
14.1
166
850
SPAT1262
SPAT
Handing over of treatment supplies
2.0
13.8
191
1045
N06AB03
ATC
fluoxetine; oral
2.5
13.8
114
489
L02BG04
ATC
letrozole; oral
13.8
13.8
23
17
SPAT1254
SPAT
Administration of medicine
2.4
13.7
127
580
N04BC05
ATC
pramipexole; oral
3.3
13.7
69
218
R51.80
ICD-10 Finland
Headache
2.3
13.5
126
578
Y50
ICPC
Male Genital, Medication/prescr/renewal
26.1
13.4
18
7
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
13.3
49
118
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
13.3
141
684
R06.5
ICD-10 Finland
Mouth breathing
2.2
13.3
137
660
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
13.2
253
1551
E66.00
ICD-10 Finland
Metabolic syndrome
2.9
13.2
84
309
L02BG03
ATC
anastrozole; oral
40.6
13.2
16
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
13.1
85
318
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
13.0
290
1867
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
13.0
209
1206
E0000UV
ATC
NA
1.7
12.9
331
2223
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
12.9
233
1399
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
12.7
500
3779
J02AC01
ATC
fluconazole; systemic
1.9
12.7
193
1090
J01FA06
ATC
roxithromycin; oral
1.7
12.5
355
2454
M79.6
ICD-10 Finland
Pain in limb
1.7
12.5
291
1896
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
131.5
12.5
13
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
12.3
158
835
A02BC01
ATC
omeprazole; systemic
1.8
12.2
233
1424
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.9
12.2
200
1160
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
16.1
12.2
19
12
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.4
12.1
108
484
T50
ICPC
Metabolic, Medication/prescr/renewal
18.3
12.1
18
10
S55
ICPC
Skin, Local injection/infiltration
27.0
12.1
16
6
UKC02
NOMESCO Finland
Cystoscopy
2.0
11.9
160
860
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
11.8
125
607
J01MA12
ATC
levofloxacin; systemic
1.9
11.8
176
986
C09CA06
ATC
candesartan; oral
1.9
11.8
200
1174
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
11.7
91
380
WX780
NOMESCO Finland
Remote monitoring CPAP
2.8
11.7
77
292
N40
ICD-10 Finland
Hyperplasia of prostate
1.8
11.6
232
1434
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
23.2
11.6
16
7
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
11.6
174
975
H02AB04
ATC
methylprednisolone; systemic
2.2
11.6
127
626
R06AE07
ATC
cetirizine; oral
1.6
11.5
365
2585
E30.09
ICD-10 Finland
Delayed puberty NOS
+∞
11.5
11
*
N05BA12
ATC
alprazolam; oral
2.3
11.5
108
497
N05CD07
ATC
temazepam; oral
2.3
11.4
105
475
AA1AD
NOMESCO Finland
CT of head and brain
1.8
11.3
208
1252
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
11.3
296
1987
R52.2
ICD-10 Finland
Other chronic pain
4.4
11.3
40
94
M01AC06
ATC
meloxicam; systemic, rectal
1.7
11.2
318
2181
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
11.2
245
1557
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
11.1
80
319
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.5
11.1
51
151
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
11.0
49
141
J05AB11
ATC
valaciclovir; oral
2.3
11.0
105
485
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
10.9
404
2968
C07AA05
ATC
propranolol; systemic
1.9
10.8
165
930
P01AB01
ATC
metronidazole; oral, rectal
1.7
10.8
279
1863
L03
ICPC
Low back symptom/complaint
1.8
10.8
192
1141
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
10.8
109
519
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
10.7
75
296
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.6
197
1189
M04AA01
ATC
allopurinol; systemic
2.1
10.4
123
627
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
10.3
54
177
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
19.0
10.3
15
8
N06AB06
ATC
sertraline; oral
2.1
10.2
112
553
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
10.2
60
212
Y05
ICPC
Scrotum/testis sympt/compl other
5.5
10.2
29
54
WVA30
SPAT
NA
3.8
10.1
42
115
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
10.1
200
1229
127
Kela drug reimbursment
Transplant complication
5.2
10.0
30
59
E66.8
ICD-10 Finland
Other obesity
3.0
10.0
57
197
E29
ICD-10 Finland
Testicular dysfunction
40.5
10.0
12
*
A98
ICPC
Health maint/preventive medicine
2.3
9.9
987
9252
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
9.7
252
1673
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
9.7
217
1383
M48.0
ICD-10 Finland
Spinal stenosis
2.2
9.7
101
486
OAB72
NOMESCO Finland
Weight control and weight loss guidance
13.5
9.7
16
12
E22.1
ICD-10 Finland
Hyperprolactinaemia
55.5
9.7
11
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
9.7
145
811
N06BA04
ATC
methylphenidate; oral
4.1
9.6
36
90
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
9.5
93
435
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
9.5
158
914
N05BA01
ATC
diazepam; systemic, rectal
2.0
9.5
125
663
C07AB07
ATC
bisoprolol; oral
1.6
9.4
371
2738
H01AC01
ATC
somatropin; parenteral
100.9
9.4
10
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
9.4
9
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
9.4
9
*
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
+∞
9.4
9
*
2572A
ICD-9 Finland
Testicular dysfunction, Other testicular hypofunction
+∞
9.4
9
*
J01FA09
ATC
clarithromycin; systemic
1.6
9.4
276
1896
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
9.3
60
226
C10AA07
ATC
rosuvastatin; oral
1.7
9.3
222
1441
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
9.3
81
360
J05AB01
ATC
aciclovir; systemic
1.8
9.3
156
909
N06AA12
ATC
doxepin; systemic
2.9
9.2
54
191
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.2
211
1350
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
9.1
78
343
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
9.1
146
836
R06AX22
ATC
ebastine; oral
1.9
9.1
137
768
SPAT1310
SPAT
Counselling related to known health issue
1.6
9.1
247
1661
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
37.0
9.0
11
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.9
9.0
53
189
R50.9
ICD-10 Finland
Fever, unspecified
1.9
8.9
141
802
M02AA07
ATC
piroxicam; topical
1.6
8.9
290
2041
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
12.7
8.9
15
12
UDC00
NOMESCO Finland
Ear microscopy
2.4
8.8
73
316
J01FF01
ATC
clindamycin; systemic
1.6
8.8
257
1757
S50
ICPC
Skin, Medication/prescr/renewal
8.7
8.8
18
21
Y08
ICPC
Sexual function sympt/compl male
9.6
8.8
17
18
P06
ICPC
Sleep disturbance
2.1
8.8
95
467
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
8.7
257
1762
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
50.4
8.7
10
*
N03AX09
ATC
lamotrigine; oral
2.7
8.7
58
221
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
8.7
153
906
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
8.7
299
2133
ZXD05
NOMESCO Finland
Urgent procedure
1.6
8.7
262
1808
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
8.5
202
1306
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.5
8.5
38
111
T29
ICPC
Endocr/metab/nutr sympt/compl other
5.0
8.5
26
53
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
8.5
77
349
J01AA04
ATC
lymecycline; systemic
1.9
8.5
118
642
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
8.4
97
489
G04CA02
ATC
tamsulosin; oral
1.6
8.4
245
1674
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
8.4
92
452
E23.05
ICD-10 Finland
Lack of TSH
90.7
8.4
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.4
361
2705
Z3231
NOMESCO Finland
Registered nurse
1.6
8.4
232
1563
A02BC04
ATC
rabeprazole; oral
2.3
8.4
78
359
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
8.3
8
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
+∞
8.3
8
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
8.3
234
1582
N06AX22
ATC
agomelatine; oral
4.1
8.3
31
78
Y99
ICPC
Genital disease male other
9.5
8.3
16
17
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.3
8.2
29
69
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
8.2
59
235
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
8.2
63
264
X58
ICD-10 Finland
Exposure to other specified factors
1.7
8.1
164
1011
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
8.1
125
705
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
8.0
217
1451
E29.8
ICD-10 Finland
Other testicular dysfunction
22.2
8.0
11
5
M25.5
ICD-10 Finland
Pain in joint
1.6
8.0
224
1513
C03CA01
ATC
furosemide; systemic
1.7
8.0
165
1025
R01AD01
ATC
beclometasone; nasal
1.8
8.0
135
787
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.0
369
2804
75210
ICD-8 Finland
Congenital anomalies of genital organs, Undescended testicle
4.3
7.9
28
67
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
7.9
32
87
L17
ICPC
Foot/toe symptom/complaint
1.7
7.9
176
1117
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
7.9
66
286
F32.1
ICD-10 Finland
Moderate depressive episode
2.8
7.9
50
187
R02
ICPC
Shortness of breath/dyspnoea
2.1
7.8
84
412
Z01.2
ICD-10 Finland
Dental examination
1.5
7.8
353
2666
L03AA02
ATC
filgrastim; parenteral
4.1
7.8
29
73
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
7.7
133
779
H05BX01
ATC
cinacalcet; oral
45.3
7.7
9
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.3
7.6
70
317
R03BA08
ATC
ciclesonide; inhalant
2.3
7.6
68
306
L08
ICPC
Shoulder symptom/complaint
1.7
7.6
153
940
N41.1
ICD-10 Finland
Chronic prostatitis
2.7
7.6
49
186
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
25.2
7.6
10
*
R03BA05
ATC
fluticasone; inhalant
1.8
7.6
140
840
R03DC03
ATC
montelukast; oral
1.8
7.5
121
695
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.5
555
4614
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
7.5
223
1527
P76
ICPC
Depressive disorder
2.5
7.5
58
242
SPAT1312
SPAT
General health counselling
1.6
7.5
239
1664
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
7.5
247
1736
M01AX17
ATC
nimesulide; oral
1.7
7.5
181
1173
SPAT1301
SPAT
No procedures
1.6
7.4
228
1573
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
80.6
7.4
8
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
7.4
153
946
C08CA01
ATC
amlodipine; oral
1.5
7.3
286
2086
N06AB05
ATC
paroxetine; oral
2.3
7.3
66
299
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.3
671
5796
G03GA05
ATC
follitropin alfa; parenteral
+∞
7.3
7
*
G03GA02
ATC
human menopausal gonadotrophin; parenteral
+∞
7.3
7
*
A02BA02
ATC
ranitidine; systemic
1.7
7.3
142
864
SPAT1263
SPAT
Sampling
1.5
7.2
333
2515
M54.2
ICD-10 Finland
Cervicalgia
2.3
7.2
63
282
KFA00
NOMESCO Finland
Exploration of testis
8.0
7.1
15
19
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.1
170
1100
Z01.9
ICD-10 Finland
Special examination, unspecified
2.7
7.1
46
176
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
7.1
299
2218
7525A
ICD-9 Finland
Congenital anomalies of genital organs, Undescended testicle[RETENTIO TESTIS (CRYPTORCHISMUS)]
8.8
7.1
14
16
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
7.1
62
279
SPAT1325
SPAT
Vaccination
1.6
7.0
221
1532
WX110
NOMESCO Finland
Local anesthesy
1.4
7.0
654
5644
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
7.0
7.0
16
23
WX320
NOMESCO Finland
Spinalanesthesy
1.6
7.0
169
1095
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
7.0
43
160
R06AX13
ATC
loratadine; oral
1.8
7.0
116
671
J01EA01
ATC
trimethoprim; systemic
2.1
7.0
80
405
H02.3
ICD-10 Finland
Blepharochalasis
3.1
6.9
36
120
A04
ICPC
Weakness/tiredness general
2.1
6.9
75
370
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
6.9
171
1114
N06AA09
ATC
amitriptyline; systemic
2.2
6.9
70
336
T90
ICPC
Diabetes non-insulin dependent
1.6
6.9
201
1368
M54.1
ICD-10 Finland
Radiculopathy
2.9
6.9
40
143
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
6.8
39
136
M05BA04
ATC
alendronic acid; oral
3.2
6.8
34
110
C08CA02
ATC
felodipine; oral
2.2
6.8
65
303
R35
ICD-10 Finland
Polyuria
2.3
6.8
62
281
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
40.3
6.8
8
*
SPAT1094
SPAT
Continuous Positive Airway Pressure
4.3
6.7
23
54
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.7
446
3606
L01
ICPC
Neck symptom/complaint
2.0
6.7
86
452
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
6.7
124
741
L04AA06
ATC
mycophenolic acid; systemic
4.0
6.7
25
64
R60.0
ICD-10 Finland
Localized oedema
2.1
6.7
76
384
A10BA02
ATC
metformin; oral
1.5
6.7
229
1621
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.6
524
4365
N06AX05
ATC
trazodone; oral
3.8
6.6
26
70
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.2
6.6
32
102
DHB50
NOMESCO Finland
Turbinoplasty
2.7
6.6
42
158
M79.1
ICD-10 Finland
Myalgia
1.9
6.6
93
511
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
6.5
75
381
Y29
ICPC
Genital symptom/complaint male other
5.1
6.5
19
38
R03AC03
ATC
terbutaline; inhalant
1.8
6.5
107
619
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.5
6.5
47
193
J01MA14
ATC
moxifloxacin; systemic
2.0
6.5
80
416
Y55
ICPC
Male Genital, Local injection/infiltration
70.3
6.4
7
*
D07AC13
ATC
mometasone; topical
1.5
6.4
238
1712
ZXA05
NOMESCO Finland
Left side
1.6
6.4
192
1313
205
Kela drug reimbursment
Chronic hypertension
1.6
6.4
189
1287
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.9
6.4
19
39
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
6.4
60
280
SBB10
NOMESCO Finland
Teeth copy
2.3
6.4
57
259
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
6.4
82
436
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
6.3
902
8369
L28
ICPC
Limited function/disability (L)
1.9
6.3
93
516
N02AA05
ATC
oxycodone; systemic
1.8
6.3
106
617
C08CA13
ATC
lercanidipine; oral
1.9
6.3
95
533
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.3
100
568
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
6.3
41
158
E23.03
ICD-10 Finland
Lack of ACTH
+∞
6.3
6
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
6.2
44
176
Y10
ICPC
Infertility/subfertility male
26.8
6.2
8
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
26.8
6.2
8
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
26.8
6.2
8
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.6
6.2
44
177
M54
ICD-10 Finland
Dorsalgia
1.8
6.2
96
545
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
6.2
90
500
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
6.2
63
304
JN4BD
NOMESCO Finland
Extensive body CT
1.9
6.2
86
470
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.4
6.2
27
80
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
6.1
72
369
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
6.1
592
5080
M01AC01
ATC
piroxicam; systemic, rectal
1.8
6.1
106
624
R06AX18
ATC
acrivastine; oral
3.5
6.1
26
75
HMAK
NOMESCO Finland
NA
1.8
6.1
104
609
A99
ICPC
Disease/condition unspecnature/site
2.2
6.1
60
284
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
6.1
280
2104
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
6.1
190
1310
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
6.1
133
837
C02AC05
ATC
moxonidine; oral
2.7
6.1
39
147

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1002
1731
33.52
307.65
6.0
2.0
nmol/l
13.0
14.6
7.43
959
1587
(3009214) Lutropin [Units/volume] in Serum or Plasma
482
332
23.92
307.65
2.1
1.3
u/l
7.9
4.6
7.23
397
273
(3021387) Prolactin [Units/volume] in Serum or Plasma
340
244
19.20
307.65
1.6
1.3
mu/l
233.4
251.5
0.48
318
231
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
629
567
22.72
307.65
3.3
1.7
pmol/l
210.1
222.3
1.20
622
537
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
679
759
19.82
307.65
3.2
1.7
nmol/l
30.0
37.4
13.66
672
737
(3023323) Follitropin [Units/volume] in Serum or Plasma
204
119
20.53
254.62
2.0
1.3
iu/l
15.2
7.5
4.64
158
93
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1030
5959
6.90
128.64
4.8
3.8
ug/l
1.4
1.9
9.45
972
5462
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
87
45
20.80
113.07
1.8
1.6
nmol/l
0.1
0.1
0.26
69
34
(3036481) Cortisol [Moles/volume] in Serum or Plasma
287
731
4.87
106.84
2.2
2.0
nmol/l
347.6
370.4
1.46
270
680
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
152
238
7.19
94.96
1.8
1.4
pmol/l
103.9
202.8
0.36
87
73
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
810
4728
3.30
79.13
3.8
3.3
%
23.1
21.0
2.74
305
1832
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
84
78
11.52
79.06
1.7
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
916
5967
3.43
69.92
3.9
2.9
pmol/l
14.4
14.8
4.56
861
5463
(3001122) Ferritin [Mass/volume] in Serum or Plasma
575
2997
2.80
64.75
3.2
2.5
ug/l
163.1
210.9
3.92
542
2821
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
54
36
15.67
61.70
1.4
1.2
u/l
20.0
8.0
3.11
45
27
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
624
3509
2.66
58.69
3.0
2.5
ug/l
0.6
0.7
0.54
346
1961
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
35
17
21.19
46.23
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1015
7768
3.25
44.82
4.8
3.5
mu/l
1.8
2.0
0.95
970
7176
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
55
63
9.11
44.31
6.7
4.8
u/l
4.4
35.4
—
19
10
(3035637) Corticotropin [Mass/volume] in Plasma
62
86
7.56
42.70
1.5
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
901
6787
2.40
35.48
8.4
8.0
u/l
72.0
77.5
6.00
871
6491
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
483
2904
2.13
33.23
2.8
2.1
nmol/l
76.7
71.4
3.78
446
2672
(40765089) Chromosome analysis panel - Blood by G-banded
37
40
9.52
31.04
1.0
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
255
1253
2.32
28.34
3.3
2.5
umol/l
16.0
14.3
1.82
233
1177
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
641
4460
1.96
27.74
6.7
7.2
umol/l
12.5
12.8
0.20
617
4279
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
21
10
21.36
27.71
1.3
1.6
%
1.6
1.5
—
21
10
(3004789) Transferrin [Mass/volume] in Serum or Plasma
241
1169
2.34
27.53
3.2
2.5
g/l
2.4
2.3
2.49
216
1097
(3013826) Glucose [Moles/volume] in Serum or Plasma
721
5244
1.97
27.12
6.5
5.6
mmol/l
6.8
6.8
0.31
685
4987
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
31
32
9.92
26.86
5.0
4.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
230
1107
2.34
26.68
3.3
2.5
%
26.6
25.1
0.80
196
983
(40761536) Microorganisms panel - Urine sediment
159
652
2.66
25.97
4.0
3.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
60
134
4.66
25.22
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
145
579
2.72
24.92
5.8
4.0
mmol/l
1.2
1.2
0.57
129
522
(3002030) Lymphocytes/100 leukocytes in Blood
612
4311
1.88
24.29
7.4
6.9
%
28.4
28.0
0.44
587
4091
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1044
8878
2.58
23.93
6.5
5.1
mmol/mol
40.1
39.8
0.48
993
8418
(3013707) Erythrocyte sedimentation rate by Westergren method
818
6343
1.95
23.92
4.3
3.7
mm/h
7.9
9.4
3.07
789
5962
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1061
9093
2.72
23.90
15.5
11.6
ml/min/173m2
83.5
88.2
10.75
953
7633
(3015377) Calcium [Moles/volume] in Serum or Plasma
392
2400
1.95
23.87
3.1
3.6
mmol/l
2.3
2.3
0.02
352
2161
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1125
9962
4.04
23.77
5.8
4.5
mmol/l
2.7
2.9
7.12
1078
9394
(3019069) Monocytes/100 leukocytes in Blood
595
4177
1.86
23.65
7.7
7.2
%
9.0
9.0
0.05
572
3979
(3006504) Eosinophils/100 leukocytes in Blood
592
4150
1.86
23.63
7.4
6.9
%
3.0
3.0
0.04
569
3939
(3037467) Urinalysis macro (dipstick) panel - Urine
740
5565
1.89
23.62
4.0
3.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
526
3558
1.87
23.48
5.6
5.8
g/l
37.1
36.4
2.25
507
3358
(3021589) Normoblasts [#/volume] in Blood
572
3977
1.85
23.34
13.1
9.7
e9/l
0.1
0.0
0.51
519
3289
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
555
3833
1.85
23.05
9.4
7.9
mmol/l
1.2
1.2
1.45
443
3307
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
515
3480
1.85
22.90
8.9
7.4
mmol/l
1.2
1.2
0.93
480
3197
(3022096) Basophils/100 leukocytes in Blood
577
4041
1.84
22.83
7.5
7.0
%
0.7
0.7
0.40
555
3848
(3018010) Neutrophils/100 leukocytes in Blood
599
4246
1.84
22.77
7.1
6.7
%
56.2
56.8
0.57
579
4040
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
456
2970
1.87
22.75
2.0
1.8
pmol/l
96.2
94.2
0.48
261
1725
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
468
3074
1.87
22.73
3.6
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1115
9869
3.54
22.52
5.5
4.2
mmol/l
4.4
4.7
11.03
1070
9358
(3031040) Bacteria [#/volume] in Urine by Automated count
654
4796
1.82
21.92
4.0
3.3
e6/l
531.5
1354.9
—
10
58
(42870588) Differential panel, method unspecified - Blood
456
2999
1.85
21.85
7.1
6.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
137
567
2.60
21.84
2.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1110
9827
3.34
21.83
5.4
4.1
mmol/l
1.2
1.3
32.83
1068
9284
(3019550) Sodium [Moles/volume] in Serum or Plasma
1094
9614
3.00
21.71
19.9
14.8
mmol/l
139.6
139.7
1.36
1079
9398
(3013115) Eosinophils [#/volume] in Blood
634
4622
1.81
21.51
7.5
7.1
e9/l
0.2
0.2
0.28
585
4108
(3023103) Potassium [Moles/volume] in Serum or Plasma
1097
9669
3.03
21.35
20.1
14.8
mmol/l
4.0
4.0
2.56
1081
9449
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
65
176
3.85
21.24
1.3
1.2
u/l
13.9
35.3
1.86
60
153
(3006315) Basophils [#/volume] in Blood
617
4482
1.79
20.99
7.0
6.7
e9/l
0.0
0.0
0.15
567
3922
(3019198) Lymphocytes [#/volume] in Blood
631
4616
1.79
20.95
7.1
6.8
e9/l
2.0
2.0
0.05
586
4104
(40760892) CBC W Ordered Manual Differential panel - Blood
344
2092
1.91
20.88
5.0
4.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
25
6
42.47
20.50
1.7
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1122
10051
3.58
20.49
17.9
11.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
614
4476
1.78
20.44
7.0
6.7
e9/l
0.6
0.6
0.59
565
3911
(3018418) pH of Serum or Plasma
355
2194
1.89
20.43
5.8
4.3
ph
7.4
7.4
0.24
115
425
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1086
9563
2.79
20.39
4.9
3.8
mmol/l
1.7
1.5
6.70
1043
9014
(3041096) Erythrocytes [Presence] in Urine by Automated
369
2319
1.86
20.09
3.1
2.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1146
10429
5.01
19.96
12.7
9.8
u/l
36.1
34.1
2.21
1121
10163
(3026782) Osmolality of Urine
275
1573
1.98
19.89
3.0
2.6
mosm/kgh2o
564.9
593.6
1.17
245
1344
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1074
9432
2.61
19.81
17.4
13.0
mg/l
21.6
25.2
3.53
904
7378
(3026493) Urate [Moles/volume] in Serum or Plasma
405
2639
1.82
19.50
2.9
2.6
umol/l
4704.5
5168.9
0.07
364
2391
(3021960) Folate [Moles/volume] in Serum or Plasma
273
1571
1.96
19.34
1.7
1.5
nmol/l
19.1
19.0
0.04
241
1381
(3002582) Erythrocytes [#/volume] in Urine
390
2519
1.82
19.29
3.7
3.0
e6/l
95.0
163.3
0.45
315
1951
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
470
3211
1.77
19.22
3.3
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
561
4034
1.75
19.15
3.4
2.9
estimate
0.0
0.0
0.32
140
677
(3035350) Ketones [Presence] in Urine by Test strip
558
4007
1.75
19.13
3.4
2.9
estimate
0.0
0.0
0.50
147
706
(3021601) Nitrite [Presence] in Urine by Test strip
557
3999
1.75
19.10
4.6
4.0
estimate
0.0
0.0
0.00
150
751
(3009508) Creatinine [Moles/volume] in Urine
435
2912
1.78
19.03
3.9
3.4
mmol/l
9.4
9.2
0.33
375
2503
(3001556) Androgen free Index in Serum or Plasma
25
9
28.34
18.77
1.4
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
285
1680
1.92
18.73
2.9
2.4
e6/l
2.1
2.7
1.33
255
1473
(3002385) Erythrocyte distribution width [Ratio]
941
7903
1.96
18.59
20.6
15.9
%
13.7
13.5
3.39
929
7731
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
494
3448
1.75
18.57
3.9
3.3
ng/l
31.6
45.9
1.22
348
2279
(3013650) Neutrophils [#/volume] in Blood by Automated count
668
5082
1.73
18.31
9.5
10.5
e9/l
4.4
4.2
0.36
611
4457
(3030467) Casts [#/volume] in Urine by Automated count
359
2300
1.81
18.01
3.7
2.9
e6/l
0.3
0.4
0.78
284
1733
(3012501) Base excess in Blood by calculation
66
202
3.40
17.99
4.3
4.4
mmol/l
2.2
2.1
0.19
47
126
(3027315) Oxygen [Partial pressure] in Blood
66
202
3.40
17.99
4.2
4.4
kpa
9.0
8.7
0.42
66
197
(3013290) Carbon dioxide [Partial pressure] in Blood
66
203
3.39
17.85
4.3
4.4
kpa
5.0
5.0
0.36
66
198
(3044889) 12 lead EKG panel
820
6636
1.78
17.76
4.0
3.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
470
3274
1.73
17.52
3.6
3.8
u/l
34.2
36.4
0.90
444
3097
(3003458) Phosphate [Moles/volume] in Serum or Plasma
213
1166
2.01
17.23
8.7
7.2
mmol/l
1.0
1.0
0.03
206
1116
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
282
1697
1.87
17.22
2.4
2.1
mg/l
3.2
2.9
1.06
238
1478
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
87
323
2.83
17.08
3.0
2.9
mg/l
1.4
1.4
0.06
82
308
(3013512) EKG study
355
2310
1.77
16.68
4.1
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
389
2601
1.74
16.60
3.7
3.3
mg/l
223.6
257.9
0.07
276
1787
(36304419) Bacteria [Presence] in Urine
350
2275
1.77
16.47
3.7
2.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
126
572
2.35
16.35
7.8
10.4
mmol/l
24.9
24.8
0.02
126
566
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
185
984
2.04
16.15
5.4
4.9
u/l
241.2
240.1
0.02
175
936
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1032
9086
2.12
15.94
5.0
4.0
mmol/l
6.1
6.0
0.37
965
8459
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
278
1707
1.82
15.75
1.3
1.2
u/ml
2.8
2.0
0.25
87
498
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
387
2616
1.71
15.70
2.7
2.3
u/l
289.1
362.1
0.53
366
2486
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
362
2403
1.73
15.68
1.8
1.7
mmol/l
1.8
1.6
2.13
305
2051
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
404
2775
1.69
15.38
2.6
2.8
u/l
55.7
59.1
0.85
377
2625
(3020682) Albumin/Creatinine [Ratio] in Urine
399
2739
1.69
15.19
4.8
4.1
mg/mmol
10.2
9.1
0.21
285
1888
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
883
7441
1.75
15.04
3.7
3.3
u/l
58.0
56.4
0.21
843
7107
(3018095) Leukocytes [#/volume] in Urine
407
2824
1.68
14.80
4.2
3.5
e6/l
96.8
61.7
0.38
327
2087
(3015736) pH of Urine
437
3092
1.66
14.71
3.0
2.8
—
5.6
—
0
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
255
1558
1.81
14.56
1.7
1.6
pmol/l
25114578.9
28762456.5
0.05
219
1349
(3032080) INR in Blood by Coagulation assay
485
3539
1.63
14.35
10.2
8.4
inr
1.2
1.2
0.96
201
1019
(1616796) Gas panel - Central venous blood
59
198
3.08
13.87
4.2
3.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
573
4380
1.60
13.84
3.4
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
263
1661
1.75
13.29
1.7
1.5
g/l
2.4
2.7
2.03
190
1148
(3023368) Bacteria identified in Blood by Culture
352
2409
1.66
13.20
5.1
4.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
302
1991
1.70
13.04
2.1
1.8
mg/l
0.9
1.1
0.69
226
1471
(3004588) Protein electrophoresis panel - Serum or Plasma
105
487
2.27
12.92
2.1
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
272
1750
1.72
12.82
2.3
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
54
181
3.08
12.73
2.8
2.6
%
18.2
17.1
0.65
29
97
(3022145) Colonoscopy Study observation
175
988
1.91
12.71
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
83
350
2.48
12.65
3.2
3.7
pmol/l
4.8
4.7
0.39
77
322
(3026008) Bacteria identified in Urine by Culture
216
1317
1.78
12.24
3.1
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
157
867
1.94
12.17
3.7
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
434
2.29
12.12
4.8
4.4
ng/l
107.7
87.6
0.63
83
396
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
166
936
1.90
12.08
2.2
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
308
2084
1.65
11.89
3.7
3.3
estimate
0.0
0.0
0.07
142
689
(3007461) Platelets [#/volume] in Blood
1157
10944
4.73
11.79
27.1
18.3
e9/l
231.9
238.9
3.80
1145
10698
(3020630) Protein [Mass/volume] in Serum or Plasma
120
610
2.08
11.72
2.1
3.1
g/l
68.3
67.0
1.32
111
573
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
350
2.41
11.72
1.1
1.2
iu/ml
80.0
138.8
1.04
28
112
(3035941) MCH [Entitic mass]
1157
10950
4.70
11.65
26.9
18.2
pg
30.4
30.5
1.63
1152
10822
(3024731) MCV [Entitic volume]
1157
10954
4.67
11.56
27.0
18.2
fl
90.4
90.5
0.40
1152
10826
(3026361) Erythrocytes [#/volume] in Blood
1157
10955
4.66
11.54
27.1
18.3
e12/l
4.9
4.8
18.98
1143
10692
(3000963) Hemoglobin [Mass/volume] in Blood
1157
10956
4.66
11.52
27.3
18.4
g/l
149.6
145.0
16.35
1152
10823
(3021440) Promyelocytes/100 leukocytes in Blood
130
685
2.01
11.51
5.0
4.9
%
0.2
0.2
0.14
37
198
(3012095) Magnesium [Moles/volume] in Serum or Plasma
233
1478
1.72
11.43
5.0
4.4
mmol/l
0.8
0.8
0.53
224
1409
(3010813) Leukocytes [#/volume] in Blood
1157
10960
4.63
11.42
27.1
18.3
e9/l
6.9
6.7
0.52
1142
10698
(3025159) Blasts/100 leukocytes in Blood
124
645
2.03
11.38
4.8
4.9
%
0.2
0.1
0.10
33
170
(3017181) Myelocytes/100 leukocytes in Blood
135
726
1.97
11.28
5.0
4.8
%
1.6
0.8
1.53
40
217
(3019309) Folate [Moles/volume] in Red Blood Cells
196
1189
1.78
11.23
1.9
1.7
nmol/l
1262.5
1157.2
0.84
141
937
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
176
1034
1.83
11.22
2.3
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
317
2193
1.61
11.07
3.2
3.1
ng/l
838.0
1162.7
1.22
244
1822
(3002179) Metamyelocytes/100 leukocytes in Blood
125
668
1.97
10.63
4.7
4.5
%
0.8
0.5
0.84
34
169
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
38
117
3.32
10.33
5.6
3.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
113
590
2.01
10.26
2.1
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
107
551
2.04
10.09
3.2
3.2
mmol/l
1.4
1.5
0.10
79
408
(3005719) IgG [Mass/volume] in Serum or Plasma
138
777
1.88
10.04
2.9
2.4
g/l
10.0
10.8
1.31
118
706
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
180
2.80
9.87
4.0
4.0
%
54.2
55.6
0.38
49
180
(3009343) pH of Capillary blood
109
572
2.00
9.75
3.3
3.2
ph
7.4
7.4
0.19
25
68
(40768804) Tissue Pathology biopsy report
395
2942
1.52
9.73
2.0
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
174
1065
1.74
9.60
2.5
2.8
ug/g
118.2
172.6
1.50
153
916
(3030905) Polymorphonuclear cells [#/volume] in Blood
47
175
2.76
9.24
3.2
3.7
e9/l
3.2
3.9
2.14
47
175
(3025941) Bacteria identified in Stool by Culture
94
478
2.05
9.18
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
91
458
2.07
9.13
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
63
282
2.30
8.47
3.1
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
181
1158
1.67
8.44
1.4
1.3
titre
234.3
365.3
1.34
21
188
(4038314)
12
16
7.57
8.42
1.5
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
234
2.42
8.29
3.2
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
193
1262
1.63
8.26
1.4
1.2
iu/ml
22.7
26.4
0.20
52
378
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
68
3.73
8.20
2.5
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
150
920
1.72
8.18
1.4
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
139
835
1.75
8.15
3.5
2.9
%
1.8
1.8
0.20
121
767
(3009542) Hematocrit [Volume Fraction] of Blood
1016
9322
1.66
8.15
18.2
13.4
%
44.1
42.5
7.04
809
7439
(3000012) Reticulocyte production index
15
27
5.61
8.03
1.3
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
187
1228
1.62
7.85
2.5
3.6
mmol/l
2.4
2.4
0.51
170
1087
(3023520) Reticulocytes [#/volume] in Blood
110
627
1.83
7.69
3.8
3.0
e9/l
77.8
70.8
0.75
80
479
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
194
1294
1.60
7.62
2.5
1.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
25
5.66
7.55
2.1
1.9
ug/l
49.6
49.1
0.01
14
25
(40768797) Stomach Pathology biopsy report
171
1109
1.63
7.53
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
153
2.67
7.52
2.9
2.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
78
3.39
7.41
2.4
2.0
%
15.0
14.2
0.12
12
33
(3017143) Hepatitis C virus Ab [Presence] in Serum
195
1320
1.57
7.18
2.1
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
465
3736
1.40
7.16
4.5
3.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
40
157
2.60
7.16
3.3
2.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
43
175
2.51
7.15
2.5
2.4
g/l
144.7
134.3
1.17
34
131
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
766
6708
1.41
7.01
3.1
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
192
1305
1.56
6.93
1.9
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
312
2349
1.45
6.86
4.7
4.7
%
89.2
88.8
0.12
304
2311
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
45
4.05
6.64
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
382
1.97
6.63
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
214
2.30
6.56
2.9
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
327
2504
1.42
6.50
2.5
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
220
1561
1.50
6.50
1.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
285
2139
1.44
6.30
7.4
8.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
168
1136
1.56
6.18
1.3
1.2
u/ml
1.5
8.8
4.41
71
500
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
65
336
1.99
6.13
2.3
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
128
813
1.64
6.11
5.5
4.3
mmol/l
1.8
1.9
0.07
108
656
(3011412) CD3 cells [#/volume] in Blood
29
105
2.81
6.08
3.2
2.7
e9/l
1.1
1.2
0.18
24
54
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
46
212
2.22
5.85
3.0
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
188
1320
1.51
5.81
2.3
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
141
931
1.58
5.75
1.5
1.2
—
—
—
0
0
(4062490)
28
103
2.76
5.72
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
107
661
1.68
5.69
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
41
183
2.29
5.63
1.5
1.7
g/l
0.6
1.0
1.57
24
138
(3007853) Bacteria identified in Skin by Aerobe culture
159
1087
1.54
5.56
2.2
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
43
198
2.22
5.49
1.3
1.4
e6/l
5.1
32.3
0.91
35
144
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
198
2.22
5.49
1.3
1.5
e6/l
183.2
1398.6
0.73
38
151
(3021447) Carbon dioxide [Partial pressure] in Venous blood
126
819
1.60
5.49
5.3
4.3
kpa
6.0
5.9
0.47
120
797
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
96
584
1.70
5.41
1.5
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
261
2.04
5.35
1.4
2.6
g/l
3.7
3.8
0.19
38
187
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
261
2.04
5.35
1.4
2.6
g/l
7.3
7.1
0.27
43
198
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
261
2.04
5.35
1.4
2.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
16
44
3.67
5.21
4.1
7.5
mg/l
86.7
68.3
—
10
35
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
97
2.72
5.19
3.0
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
25
92
2.75
5.12
3.2
2.8
pg
33.3
33.9
0.36
25
92
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
245
2.04
5.10
1.5
2.7
g/l
2.9
3.1
0.48
42
193
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
31
4.23
5.10
2.6
1.7
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
104
2.63
5.08
1.4
1.2
g/l
6.8
7.3
0.14
11
72
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
104
2.63
5.08
1.4
1.2
g/l
0.4
0.4
0.08
11
70
(3022313) Gas panel - Capillary blood
75
434
1.78
5.05
3.2
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
155
1076
1.51
5.04
3.3
3.4
umol/l
8.6
9.5
0.19
142
968
(3044290) Cell count panel - Cerebral spinal fluid
40
186
2.19
5.02
1.3
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
105
2.61
4.99
1.4
1.2
g/l
2.9
3.1
0.16
11
73
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
124
2.46
4.91
2.4
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
77
454
1.74
4.87
1.9
2.1
u/l
43.1
39.6
0.75
69
407
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
187
1358
1.45
4.85
3.4
2.8
e6/l
0.5
0.5
0.00
105
747
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
45
224
2.05
4.76
3.8
3.7
mg/l
36.9
37.4
0.02
30
175
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
127
857
1.54
4.72
2.5
2.5
g/l
0.2
0.2
0.30
121
794
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
47
240
2.00
4.65
10.0
7.6
iu/ml
135.8
725.1
—
9
39
(3000492) Spirometry study
167
1201
1.46
4.56
1.6
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
94
596
1.63
4.55
2.6
3.3
e9/l
4.6
4.1
1.30
83
489
(3034860) Kappa light chains.free [Mass/volume] in Serum
44
224
2.00
4.40
3.8
3.7
mg/l
70.1
93.4
0.27
29
174
(3000991) Gas panel - Venous blood
118
796
1.54
4.40
12.0
12.0
—
—
—
0
0
(3017704) Immunofixation for Urine
15
45
3.36
4.33
2.4
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
233
1.97
4.30
1.3
1.5
ug/g
350.4
265.3
2.25
31
135
(3044927) Protein electrophoresis panel - Urine
20
72
2.81
4.30
1.3
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
61
2.98
4.29
3.3
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
193
1442
1.40
4.27
3.4
2.7
e6/l
0.5
0.9
2.00
110
825
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
51
3.17
4.21
1.2
1.2
mmol/l
12.4
12.8
—
8
27
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
36
3.64
4.21
1.1
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
18
63
2.89
4.07
2.3
2.3
min
506.5
502.7
0.04
11
44
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
22
86
2.59
4.06
1.2
1.2
pmol/l
309.5
271.5
0.20
17
70
(36660697) Celiac disease serology panel - Serum
94
615
1.57
4.02
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
29
133
2.21
3.82
4.8
4.4
%
2.4
1.5
0.40
24
118
(3021879) Hepatitis B virus core Ab [Presence] in Serum
125
880
1.47
3.82
1.8
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
44
3.21
3.78
2.5
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
248
1967
1.33
3.75
2.5
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
148
2.12
3.71
2.9
1.6
—
—
—
0
0
(4024509)
14
45
3.14
3.65
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
101
687
1.51
3.65
2.0
2.6
ml/min/173m2
61.9
72.3
1.40
42
234
(3048929) Epstein Barr virus Ab [Presence] in Serum
60
361
1.70
3.60
1.2
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
361
1.70
3.60
1.5
1.8
g/l
1.5
1.5
0.19
52
312
(3028707) Methadone [Presence] in Urine by Screen method
45
249
1.84
3.58
3.3
4.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
50
286
1.78
3.57
1.8
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
34
171
2.02
3.56
4.3
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
144
1058
1.41
3.51
10.6
10.7
mmol/l
1.0
1.0
0.02
127
827
(21494890) Protein electrophoresis panel - 24 hour Urine
18
71
2.56
3.30
1.5
2.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
136
2.08
3.24
1.1
1.1
u/ml
2.2
2.1
0.04
14
69
(3004451) EKG impression Narrative
16
60
2.69
3.23
1.1
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
902
1.42
3.21
2.4
1.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
15
55
2.75
3.16
3.1
1.9
u/l
188.7
204.5
0.38
15
55
(3000093) Morphology [Interpretation] in Blood Narrative
19
80
2.40
3.07
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
218
1745
1.31
3.06
3.5
3.7
ng/l
748.3
663.8
0.07
165
1342
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
16
5.03
3.05
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
16
5.03
3.05
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
29
3.47
3.05
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
196
1.86
3.05
1.6
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
204
1.84
3.02
1.2
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
17
69
2.49
2.96
1.9
2.4
—
1.6
—
0
6
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
163
1.93
2.92
2.5
1.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
58
368
1.61
2.89
2.2
1.8
mg/l
5.1
4.6
0.07
46
265
(3028300) Cannabinoids [Presence] in Urine
89
621
1.47
2.89
2.6
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
147
1123
1.35
2.85
1.4
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
83
2.31
2.85
2.4
2.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
83
2.31
2.85
2.4
2.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
83
2.31
2.85
2.4
2.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
41
239
1.74
2.81
1.1
1.1
u/ml
0.7
5.6
—
5
32
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
241
1976
1.28
2.80
2.0
2.0
%
1.5
1.5
0.26
216
1780
(3037121) Protein [Mass/volume] in Urine
49
301
1.66
2.78
3.6
4.1
g/l
0.3
0.3
0.02
29
178
(1001926) Buprenorphine [Presence] in Urine by Screen method
71
477
1.52
2.77
2.6
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
124
2.04
2.77
2.7
1.7
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
6
8.36
2.75
3.0
3.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
111
2.09
2.74
2.5
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
87
612
1.46
2.72
2.6
2.7
—
—
—
0
0
(4010399)
86
604
1.46
2.71
1.3
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
175
1.85
2.70
1.1
1.1
u/ml
1.7
1.6
0.02
15
70
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
258
1.69
2.67
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
86
606
1.45
2.67
2.7
2.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.0
3.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.0
3.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.0
3.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.4
2.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.2
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
43
2.81
2.65
3.0
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
123
925
1.37
2.64
2.6
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
82
575
1.46
2.62
2.6
2.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
107
2.08
2.58
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
87
620
1.44
2.56
2.6
2.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
48
301
1.62
2.54
2.3
2.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
49
311
1.60
2.47
3.3
2.9
g/l
3.8
3.7
0.13
49
298
(3011648) Oxygen content in Venous blood
20
96
2.10
2.44
3.1
2.3
%
13.3
11.6
0.68
20
96
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
25
131
1.93
2.42
1.0
1.2
—
41.6
—
0
10
(3004775) Volume in Urine collected for unspecified duration
18
83
2.19
2.41
2.2
2.3
ml
868.7
614.9
1.18
11
52
(3024928) Oxygen saturation in Venous blood
36
213
1.71
2.38
4.9
3.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
183
1.77
2.37
1.1
1.1
u/ml
2.9
7.6
1.67
19
95
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
132
1.91
2.37
2.3
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
104
2.04
2.37
2.6
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
38
229
1.68
2.35
2.1
3.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
44
277
1.61
2.31
1.7
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
238
1.66
2.31
1.8
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
155
1.83
2.31
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
59
2.39
2.29
3.2
3.2
u/ml
676.9
1237.0
0.70
14
59
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
41
2.70
2.28
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
99
2.04
2.27
5.2
5.2
—
—
—
0
0
(4094501)
50
327
1.55
2.25
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
127
986
1.32
2.24
5.3
4.2
%
27.2
28.7
0.88
101
716
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
248
1.63
2.24
1.2
1.9
nmol/l
1.1
0.9
1.11
33
221
(3011288) Drugs identified in Urine by Screen method
58
393
1.50
2.23
4.6
4.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
107
1.98
2.21
1.7
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
29
165
1.78
2.20
1.1
1.2
—
3.1
—
0
11
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
116
892
1.33
2.19
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
168
1359
1.28
2.18
2.1
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
266
1.60
2.17
2.8
2.3
ug/min
341.2
143.7
0.45
26
158
(3019225) pH of Specimen
93
692
1.37
2.17
5.3
4.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
49
2.46
2.10
1.1
1.1
iu/ml
162.1
275.1
0.80
12
49
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
138
1.83
2.10
2.7
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
214
1.66
2.08
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
82
2.09
2.07
1.1
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
22
117
1.90
2.07
1.2
1.1
mmol/l
7.0
7.0
0.00
17
91
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
50
2.41
2.03
3.2
2.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
85
632
1.37
2.01
13.5
13.3
%
0.6
0.7
1.08
85
626
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
98
1.95
1.96
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
14
64
2.20
1.95
1.1
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
11
4.56
1.94
1.6
2.6
ng/l
138.9
154.8
—
5
11
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
6
16
3.76
1.93
16.7
11.1
umol/l
0.5
0.4
—
6
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
219
1.62
1.92
1.7
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
71
2.13
1.92
1.9
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
39
2.58
1.92
3.4
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
39
2.58
1.92
3.4
3.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
85
2.01
1.90
3.3
3.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
36
228
1.60
1.89
1.9
1.5
u/ml
106.4
117.7
—
10
43
(3020191) Ethanol [Moles/volume] in Serum or Plasma
23
129
1.80
1.86
1.3
1.5
promille
1.4
1.5
0.12
14
102
(3048879) Bone marrow aspiration report
8
28
2.87
1.86
4.1
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
46
2.40
1.85
1.2
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
6
17
3.54
1.84
1.0
2.6
mmol/l
1.2
1.2
—
6
17
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
40
2.51
1.84
3.4
3.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
872
1.30
1.83
2.8
2.9
u/l
31.5
97.7
0.70
99
789
(3022217) INR in Platelet poor plasma by Coagulation assay
129
1034
1.28
1.83
16.5
20.8
inr
1.0
1.2
6.31
17
143
(3023410) Appearance of Cerebral spinal fluid
18
94
1.93
1.80
1.6
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
83
628
1.35
1.78
3.0
2.8
ng/l
187.3
160.1
0.20
74
553
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
88
1.95
1.75
2.8
3.1
%
38.5
39.1
—
6
24
(3011397) Hemoglobin [Presence] in Urine by Test strip
208
1771
1.21
1.72
3.5
3.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
48
2.30
1.70
2.5
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
203
1.59
1.69
1.2
1.1
u/ml
4.2
1.9
0.30
15
82
(40768443) Skin Pathology biopsy report
48
334
1.46
1.68
1.3
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
31
2.59
1.66
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
25
2.81
1.65
25.7
9.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
229
1.54
1.64
1.8
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
49
2.26
1.64
2.5
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
55
395
1.41
1.63
4.1
4.1
mmol/l
25.8
25.0
0.98
49
382
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
542
1.35
1.62
14.7
14.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
174
1.62
1.62
1.1
1.1
u/ml
0.5
3.7
—
6
49
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
64
476
1.36
1.56
2.1
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
44
2.28
1.53
2.7
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
41
283
1.46
1.51
1.6
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
27
2.60
1.51
1.0
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
86
1.87
1.50
2.7
4.7
%
52.6
57.8
0.31
11
68
(40757373) Influenza virus identified in Isolate
6
21
2.87
1.50
1.2
2.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
77
593
1.32
1.50
7.8
6.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
131
1.69
1.50
1.1
1.2
—
1.7
—
0
10
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
259
1.48
1.49
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
203
1749
1.19
1.49
3.4
3.2
kg/l
1.0
1.0
0.48
21
212
(4035726)
82
639
1.30
1.48
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
117
1.72
1.45
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
52
2.13
1.44
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
253
1.48
1.44
1.3
1.2
u/ml
286.8
278.3
0.06
21
157
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
125
1.69
1.44
1.2
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
16
3.13
1.44
1.0
2.4
mmol/l
1.2
1.2
—
5
16
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
19
110
1.74
1.43
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
135
1.64
1.36
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
41
290
1.43
1.36
1.7
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
497
1.33
1.35
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
35
241
1.47
1.33
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
61
1.98
1.33
1.2
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
184
1.53
1.32
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
309
1.41
1.32
3.4
3.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
35
242
1.46
1.31
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
35
242
1.46
1.31
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
34
2.36
1.29
3.4
4.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
23
146
1.59
1.26
1.0
1.1
u/ml
4.3
3.1
—
10
67
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
115
1.66
1.25
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
47
347
1.37
1.24
2.9
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
36
2.23
1.24
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
155
1.56
1.23
1.0
1.1
u/ml
0.4
2.8
—
9
69
(3003694) ABO and Rh group [Type] in Blood
278
2496
1.15
1.23
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
246
1.44
1.22
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
20
124
1.62
1.21
3.4
2.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
26
2.31
1.19
1.5
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
38
2.11
1.18
1.3
2.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
157
1.54
1.18
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
157
1.54
1.18
1.5
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
282
1.40
1.17
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
79
1.78
1.17
1.3
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
36
257
1.41
1.16
3.6
3.5
umol/l
44.5
36.9
0.78
30
227
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
87
1.73
1.15
2.6
2.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
72
1.81
1.15
1.9
3.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
20
2.51
1.15
2.4
2.0
—
—
—
0
0
(3020891) Body temperature
50
379
1.33
1.14
7.7
5.2
—
—
—
0
0
(4027681)
11
58
1.91
1.12
1.2
1.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
8
40
2.01
1.12
1.3
1.7
%
—
3.5
—
0
8
(3004716) Salmonella sp identified in Stool by Organism specific culture
51
389
1.33
1.12
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
88
1.71
1.11
2.3
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
88
1.71
1.11
2.4
3.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
41
1.96
1.09
7.8
3.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
3.0
—
49643.7
—
0
9
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
32
2.19
1.08
1.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
81
660
1.24
1.08
3.1
3.1
—
—
—
0
0
(44790048)
18
113
1.60
1.06
2.6
1.9
—
—
—
0
0
(44790047)
18
113
1.60
1.06
2.6
1.9
—
—
—
0
0
(44790049)
18
113
1.60
1.06
2.6
1.9
—
—
—
0
0
(44806118)
18
113
1.60
1.06
2.6
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
146
1.52
1.03
1.6
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
46
1.96
1.03
1.8
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
255
1.38
1.03
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
130
1.55
1.03
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
25
171
1.47
1.03
2.8
2.5
titre
640.0
1491.4
—
5
14
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
47
1.92
1.02
2.9
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
47
1.92
1.02
2.9
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
53
1.89
1.01
1.5
1.2
nmol/l
159.5
150.0
—
10
53
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
48
1.88
1.00
2.2
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
76
1.72
0.99
1.2
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
134
0.52
0.99
24.1
14.6
nmol/l
827.9
819.1
—
7
129
(4211845)
5
23
2.18
0.98
2.4
2.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
23
2.18
0.98
2.0
1.3
%
100.8
104.3
—
5
23
(3023419) Bacteria identified in Sputum by Culture
19
124
1.54
0.97
2.9
3.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
116
1.56
0.97
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
182
1.44
0.96
1.8
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
101
1.59
0.94
1.4
1.7
%
66.1
61.9
—
7
68
(3022621) pH of Urine by Test strip
54
429
1.27
0.91
2.5
2.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
44
342
1.30
0.88
3.0
2.5
%
90.1
91.0
0.10
38
329
(4268621)
18
119
1.52
0.88
2.7
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
186
1.41
0.87
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
30
2.01
0.87
1.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
132
1157
1.16
0.84
1.8
1.6
—
—
—
0
0
(44813793)
8
45
1.78
0.84
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
129
1.48
0.83
2.2
1.9
—
—
—
0
0
(4146454)
6
112
0.53
0.83
3.7
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
73
1.65
0.81
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
29
216
1.35
0.79
1.8
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
313
1.29
0.78
3.3
3.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
36
279
1.30
0.76
1.2
1.1
—
0.7
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
36
280
1.29
0.75
9.3
8.0
mmol/l
1.4
1.3
0.34
30
243
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
308
1.28
0.73
4.3
3.0
u/ml
0.3
0.3
0.48
20
164
(3047189) Immunofixation for 24 hour Urine
7
39
1.80
0.72
1.3
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
60
1.67
0.72
2.1
3.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
309
1.27
0.71
1.6
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
318
1.27
0.71
1.7
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
5.4
4.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
127
1.42
0.68
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
127
1.42
0.68
2.4
2.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
30
232
1.30
0.66
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
30
232
1.30
0.66
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
78
1.54
0.65
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
56
468
1.21
0.65
2.5
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
29
1.73
0.64
13.0
8.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
29
1.73
0.64
1.8
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
12
79
1.52
0.62
9.2
10.5
u/ml
29.2
159.4
—
6
38
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.8
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.8
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
3.0
1.3
ug/l
11.9
8.4
—
8
44
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.8
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
244
1.28
0.61
1.1
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
139
1.37
0.60
1.3
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.8
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.8
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.8
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
22
0.00
0.59
0.0
4.0
—
4470.4
—
0
22
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
53
1.51
0.58
1.3
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
36
1.67
0.56
1.5
1.2
—
65.0
—
0
6
(3042733) HLA Ab [Presence] in Serum
8
55
1.46
0.56
8.5
4.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
230
1.27
0.55
1.4
1.3
miu/ml
123.6
184.8
0.47
11
92
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
37
1.62
0.55
2.3
2.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
38
1.58
0.54
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
60
1.50
0.54
1.8
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
99
1.42
0.54
2.2
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
63
1.43
0.52
1.8
1.4
—
—
—
0
0
(4198724)
12
83
1.45
0.52
1.3
4.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
65
1.39
0.50
1.0
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
41
1.47
0.50
2.0
2.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
67
1.50
0.49
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
101
1.39
0.49
2.1
1.7
—
—
—
0
0
(3036489) Thrombin time
44
372
1.19
0.49
3.1
2.3
s
21.4
21.6
0.15
35
327
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
47
1.49
0.47
2.9
2.9
ug/l
14.7
537.4
—
7
41
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
102
1.38
0.47
2.2
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
102
1.38
0.47
2.1
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
102
1.38
0.47
2.2
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
102
1.38
0.47
2.1
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
164
1.29
0.46
4.5
3.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
16
120
1.34
0.46
1.4
1.2
mmol/l
75.2
65.7
0.29
11
99
(4133840)
7
50
1.40
0.45
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.3
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
70
1.43
0.41
1.5
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
96
1.36
0.41
1.5
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
40
342
1.18
0.41
7.4
4.7
mmol/l
1.3
1.4
0.25
40
336
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
33
1.52
0.41
13.0
7.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
141
1.28
0.40
1.3
1.8
iu/l
2.6
5.6
—
5
49
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
485
1.14
0.39
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
178
1.24
0.39
1.6
1.2
u/ml
2.4
5.0
—
7
59
(40768795) Lymph node Pathology biopsy report
12
90
1.34
0.36
1.2
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
35
302
1.16
0.34
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
163
1.23
0.34
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
127
1.26
0.33
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
127
1.26
0.33
1.3
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
23
191
1.21
0.33
1.1
1.1
g/l
1.4
1.5
0.71
23
172
(3010144) Erythrocytes [#/volume] in Synovial fluid
6
88
0.68
0.33
1.0
1.2
e6/l
13103.2
60014.3
—
6
69
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
47
1.28
0.32
9.3
6.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
92
1.31
0.32
1.3
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
52
1.35
0.31
1.3
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
148
1.22
0.29
1.4
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
185
1.19
0.29
1.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
94
1.28
0.28
2.9
4.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
85
1.30
0.28
1.3
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
85
1.30
0.28
1.3
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
64
1.25
0.27
1.6
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
20
168
1.19
0.27
3.5
3.5
mmol/l
1.4
1.7
1.40
20
163
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
196
1.18
0.27
1.5
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
340
0.88
0.25
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
157
0.83
0.22
1.3
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
1.4
1.1
miu/ml
1366.8
1408.6
—
5
41
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
41.5
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
43
1.16
0.21
2.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
20
173
1.16
0.21
5.0
3.0
mg/l
18.7
25.8
0.45
15
111
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
394
1.09
0.19
1.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
51
1.18
0.19
2.0
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
60
1.17
0.17
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
91
1.21
0.17
1.9
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
62
1.13
0.17
2.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
83
1.08
0.14
1.6
1.6
g/l
31.2
33.3
—
9
73
(3004616) Nuclear Ab [Presence] in Serum
9
83
1.08
0.14
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
93
1.18
0.14
1.5
1.5
g/l
0.9
1.1
0.59
11
93
(3000475) Leukocytes [#/volume] in Synovial fluid
23
212
1.09
0.10
1.3
1.6
e6/l
19958.1
16496.7
0.15
17
160
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
101
1042
0.97
0.10
9.8
6.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
47
1.06
0.09
1.4
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
47
1.06
0.09
1.4
2.1
—
260.4
—
0
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
165
1.09
0.08
1.1
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
57
1.05
0.08
2.5
5.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
61
0.82
0.08
1.4
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
61
0.82
0.08
1.4
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
64
1.09
0.08
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
71
0.84
0.07
1.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
77
1.04
0.07
1.6
1.7
—
—
—
0
0
(4034850)
29
304
0.95
0.05
17.8
9.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
90
1.11
0.05
1.6
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
327
1.04
0.05
1.7
1.6
iu/ml
0.0
0.3
—
9
72
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
170
0.94
0.04
1.9
1.2
u/ml
1.7
4.6
—
9
86
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
141
1.06
0.03
1.3
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
93
1.08
0.02
3.6
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
93
1.08
0.02
1.8
3.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
85
841
1.01
0.01
2.7
2.2
ug/l
10.2
10.1
0.01
75
772
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
114
0.96
0.00
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
71
708
1.00
0.00
4.7
5.1
ug/l
21.0
24.0
0.07
64
594
(4306422)
19
191
0.99
0.00
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
166
1665
1.00
0.00
1.3
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
49
1.02
0.00
1.0
1.3
—
3.4
—
0
5
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.7
—
3.1
—
0
8
(3017569) Oxygen content in Arterial blood
5
49
1.02
0.00
1.2
3.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
55
0.91
0.00
1.4
1.7
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
7
71
0.99
0.00
1.3
1.4
mmol/l
8.2
6.3
—
7
66
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.7
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.3
—
511.9
—
0
7
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
12.9
—
0
6
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
41.5
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.3
—
0
5
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
7.9
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1696.0
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_TESTICHYPO and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
E4_TESTICHYPO 1.58 [1.3, 1.91] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 243 out of 2410 males with E4_TESTICHYPO died.

Mortality risk

Mortality risk for people of age

years, who have E4_TESTICHYPO.

N-year risk Females Males
1 No data 0.265%
5 No data 1.557%
10 No data 4.102%
15 No data 7.786%
20 No data 13.192%

Relationships between endpoints

↥

Index endpoint: E4_TESTICHYPO – Testicular hypofunction

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data